These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7540011)
1. Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin. Kuller JA; Sellati LE; Chescheir NC; Helwick JJ; Lincoln-Boyea B; Boor-Smith C; McCoy MC; Katz VL Am J Perinatol; 1995 Mar; 12(2):93-7. PubMed ID: 7540011 [TBL] [Abstract][Full Text] [Related]
2. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249 [TBL] [Abstract][Full Text] [Related]
3. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Lepage N; Chitayat D; Kingdom J; Huang T Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511 [TBL] [Abstract][Full Text] [Related]
4. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
5. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels. Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899 [TBL] [Abstract][Full Text] [Related]
6. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein. Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411 [TBL] [Abstract][Full Text] [Related]
7. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Dick PT CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836 [TBL] [Abstract][Full Text] [Related]
8. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
10. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551 [TBL] [Abstract][Full Text] [Related]
11. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Benn PA; Horne D; Briganti S; Rodis JF; Clive JM Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527 [TBL] [Abstract][Full Text] [Related]
12. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]
13. Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications. Komischke K; Searle K; Enders G Prenat Diagn; 1997 Nov; 17(11):1039-46. PubMed ID: 9399352 [TBL] [Abstract][Full Text] [Related]
14. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Gonen R; Perez R; David M; Dar H; Merksamer R; Sharf M Obstet Gynecol; 1992 Jul; 80(1):83-6. PubMed ID: 1603504 [TBL] [Abstract][Full Text] [Related]
15. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin]. Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210 [TBL] [Abstract][Full Text] [Related]
16. The relationship between perinatal outcome of singleton pregnancies and isolated highly elevated levels of maternal serum human chorionic gonadotropin at mid-gestation. Tavor O; Shohat M; Lipitz S Isr Med Assoc J; 2007 Jul; 9(7):509-12. PubMed ID: 17710780 [TBL] [Abstract][Full Text] [Related]
17. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282 [TBL] [Abstract][Full Text] [Related]
18. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation. Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757 [TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related]